Trial Profile
Comparative evaluation of the effects of hydrochlorothiazide and nebivolol versus hydrochlorothiazide and irbesartan on endothelial function in patients with newly diagnosed hypertension [VALUTAZIONE COMPARATIVA DEGLI EFFETTI SULLA FUNZIONE ENDOTELIALE DEL TRATTAMENTO CON NEBIVOLOLO E IDROCLOROTIAZIDE VS IRBESARTAN E IDROCLOROTIAZIDE IN PAZIENTI CON IPERTENSIONE ARTERIOSA NEO-DIAGNOSTICATA]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Mar 2012
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Hydrochlorothiazide; Irbesartan
- Indications Essential hypertension
- Focus Pharmacodynamics
- Acronyms NINFE
- Sponsors Laboratorios Menarini
- 08 Mar 2012 Results published in the International Journal of Cardiology.
- 27 Aug 2011 New trial record